PETA MURPHY MP
MEMBER FOR DUNKLEY
PARLIAMENT HOUSE, CANBERRA
THURSDAY, 22 OCTOBER 2020
SUBJECT: Breast Cancer drug Faslodex.
PETA MURPHY, MEMBER FOR DUNKLEY: Hi, Peta Murphy, Member for Dunkley. I’m out here today because October is Breast Cancer Awareness Month.
As someone who is living with breast cancer and undergoing treatment for breast cancer, I thought I would be spending Breast Cancer Awareness Month encouraging women to get check-ups and encouraging family and friends of women and men living with breast cancer to learn all they can about how they can be supportive.
I didn’t think I’d be out here today calling on the Minister for Health to make sure that a drug, Faslodex, that was approved by the Pharmaceutical Advisory Committee in July for treatment for women with stage four breast cancer will get listed on the PBS.
Faslodex was approved by the experts in July of this year, and we’ve learnt that negotiations have fallen apart to make sure that this drug is available to women with stage four breast cancer. Three months is a long time, a long time, for someone living with terminal breast cancer and it means the world to people who have access to Faslodex to be able to extend the time they can spend with family and friends.
Up to 500 women are now facing the prospect of paying $1,600 a month for that drug, instead of as low as $6.60 if it was listed on the PBS.
The Minister for Health has said he would list all drugs on the PBS that are approved by the expert advisory committee, no ifs, no buts. This is the time that he needs to deliver on that promise and make sure that Australian women and men who are living with stage four cancer aren’t left behind and are able to access and afford a drug which will extend their lives in many cases - and not have to worry about how to pay for it as well as everything else that they’re doing.
MEDIA CONTACT: DYLAN STEED 0400 615 862
Authorised by Paul Erickson, ALP, Canberra.